CoChat

VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling

Open access
Benn, Andreas, Bredow, Clara, Casanova, Isabel, Vukičević, Slobodan, Knaus, Petra · 2016 · Journal of Cell Science
Cited by 81

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Several vascular disorders, such as aberrant angiogenesis, atherosclerosis and pulmonary hypertension, have been linked to dysfunctional BMP signaling. Vascular hyperpermeability via distortion of endothelial cell adherens junctions is a common feature of these diseases, but the role of BMPs in this process has not been investigated. BMP signaling is initiated by binding of ligand to, and activation of, BMP type I (BMPRI) and type II (BMPRII) receptors. Internalization of VE-cadherin as well as c-Src kinase-dependent phosphorylation have been implicated in the loosening of cell–cell contacts, thereby modulating vascular permeability. Here we demonstrate that BMP6 induces hyperpermeabilization of human endothelial cells by inducing internalization and c-Src-dependent phosphorylation of VE-cadherin. Furthermore, we show BMP-dependent physical interaction of VE-cadherin with the BMP receptor ALK2 (BMPRI) and BMPRII, resulting in stabilization of the BMP receptor complex and, thereby, the support of BMP6-Smad signaling. Our results provide first insights into the molecular mechanism of BMP-induced vascular permeability, a hallmark of various vascular diseases, and provide the basis for further investigations of BMPs as regulators of vascular integrity, both under physiological and pathophysiological conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/jcs.179960

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 65

  1. Adam, 2010, Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers, J. Biol. Chem., 285, 7045, 10.1074/jbc.M109.079277 · DOI · Paper page
  2. Allalou, 2009, BlobFinder, a tool for fluorescence microscopy image cytometry, Comput. Methods Programs Biomed., 94, 58, 10.1016/j.cmpb.2008.08.006 · DOI
  3. Andriopoulou, 1999, Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions, Arterioscler. Thromb. Vasc. Biol., 19, 2286, 10.1161/01.ATV.19.10.2286 · DOI · Paper page
  4. Angelini, 2006, TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia, Am. J. Physiol. Lung Cell. Mol. Physiol., 291, L1232, 10.1152/ajplung.00109.2006 · DOI · Paper page
  5. Bauer, 2005, Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis, Proc. Natl. Acad. Sci. USA, 102, 204, 10.1073/pnas.0406092102 · DOI · Paper page
  6. Behzadian, 2001, TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function, Invest. Ophthalmol. Vis. Sci., 42, 853
  7. Bhushan, 2013, miR-181a promotes osteoblastic differentiation through repression of TGF-beta signaling molecules, Int. J. Biochem. Cell Biol., 45, 696, 10.1016/j.biocel.2012.12.008 · DOI
  8. Bravi, 2014, VE-cadherin at a glance, Cell Tissue Res., 355, 515, 10.1007/s00441-014-1843-7 · DOI
  9. Cai, 2012, BMP signaling in vascular diseases, FEBS Lett., 586, 1993, 10.1016/j.febslet.2012.04.030 · DOI · Paper page
  10. Chen, 2003, Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling, Science, 301, 1394, 10.1126/science.1083195 · DOI · Paper page
  11. Corada, 2001, Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability, Blood, 97, 1679, 10.1182/blood.V97.6.1679 · DOI · Paper page
  12. Cuny, 2008, Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors, Bioorg. Med. Chem. Lett., 18, 4388, 10.1016/j.bmcl.2008.06.052 · DOI · Paper page
  13. Dejana, 2008, The role of adherens junctions and VE-cadherin in the control of vascular permeability, J. Cell Sci., 121, 2115, 10.1242/jcs.017897 · DOI · Paper page
  14. Derwall, 2012, Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 32, 613, 10.1161/ATVBAHA.111.242594 · DOI · Paper page
  15. Dvorak, 1996, The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation, J. Leukoc. Biol., 59, 100, 10.1002/jlb.59.1.100 · DOI · Paper page
  16. Dyer, 2014, The role of BMPs in endothelial cell function and dysfunction, Trends Endocrinol. Metab., 25, 472, 10.1016/j.tem.2014.05.003 · DOI · Paper page
  17. Ehrlich, 2012, Oligomeric interactions of TGF-beta and BMP receptors, FEBS Lett., 586, 1885, 10.1016/j.febslet.2012.01.040 · DOI · Paper page
  18. Eliceiri, 1999, Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability, Mol. Cell, 4, 915, 10.1016/S1097-2765(00)80221-X · DOI · Paper page
  19. Esser, 1998, Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells, J. Cell Sci., 111, 1853, 10.1242/jcs.111.13.1853 · DOI · Paper page
  20. Gabriel, 2009, Measuring plasma membrane protein endocytic rates by reversible biotinylation, J. Vis. Exp., e1669, 10.3791/1669 · doi:10.3791/1669
  21. Gavard, 2006, VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin, Nat. Cell Biol., 8, 1223, 10.1038/ncb1486 · DOI · Paper page
  22. Gavard, 2008, Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia, Dev. Cell, 14, 25, 10.1016/j.devcel.2007.10.019 · DOI · Paper page
  23. Gilboa, 2000, Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors, Mol. Biol. Cell, 11, 1023, 10.1091/mbc.11.3.1023 · DOI · Paper page
  24. Goddard, 2013, Cellular and molecular regulation of vascular permeability, Thromb. Haemost., 109, 407, 10.1160/TH12-09-0678 · DOI
  25. Goumans, 2002, Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors, EMBO J., 21, 1743, 10.1093/emboj/21.7.1743 · DOI · Paper page
  26. Ha, 2008, A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor, J. Biol. Chem., 283, 7261, 10.1074/jbc.M702881200 · DOI · Paper page
  27. Hamdy, 1997, Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue, Cancer Res., 57, 4427
  28. Hartung, 2006, Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling, Mol. Cell. Biol., 26, 7791, 10.1128/MCB.00022-06 · DOI · Paper page
  29. Helbing, 2011, BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium, Blood, 118, 5040, 10.1182/blood-2011-03-339762 · DOI
  30. Helbing, 2013, Inhibition of BMP activity protects epithelial barrier function in lung injury, J. Pathol., 231, 105, 10.1002/path.4215 · DOI
  31. Hiepen, 2014, BMP2-induced chemotaxis requires PI3K p55gamma/p110alpha-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5beta recruitment at the cytocortex, BMC Biol., 12, 43, 10.1186/1741-7007-12-43 · DOI
  32. Hussein, 2014, Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy, Exp. Eye Res., 125, 79, 10.1016/j.exer.2014.05.012 · DOI
  33. Iyer, 2004, VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function, Am. J. Physiol. Lung Cell. Mol. Physiol., 286, L1143, 10.1152/ajplung.00305.2003 · DOI
  34. Korchynskyi, 2002, Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter, J. Biol. Chem., 277, 4883, 10.1074/jbc.M111023200 · DOI · Paper page
  35. Kronstein, 2012, Caveolin-1 opens endothelial cell junctions by targeting catenins, Cardiovasc. Res., 93, 130, 10.1093/cvr/cvr256 · DOI · Paper page
  36. Kumar, 2009, Molecular mechanisms of endothelial hyperpermeability: implications in inflammation, Expert Rev. Mol. Med., 11, e19, 10.1017/S1462399409001112 · DOI · Paper page
  37. Lampugnani, 1995, The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin), J. Cell Biol., 129, 203, 10.1083/jcb.129.1.203 · DOI · Paper page
  38. Lampugnani, 2006, Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments, J. Cell Biol., 174, 593, 10.1083/jcb.200602080 · DOI · Paper page
  39. Lawler, 1997, The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues, J. Biol. Chem., 272, 14850, 10.1074/jbc.272.23.14850 · DOI · Paper page
  40. Lee, 2012, BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2, J. Orthop. Res., 30, 1985, 10.1002/jor.22160 · DOI
  41. Lin, 1998, beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor, J. Biol. Chem., 273, 31640, 10.1074/jbc.273.48.31640 · DOI · Paper page
  42. Luttrell, 1999, Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes, Science, 283, 655, 10.1126/science.283.5402.655 · DOI · Paper page
  43. Pepper, 1993, Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis, Exp. Cell Res., 204, 356, 10.1006/excr.1993.1043 · DOI · Paper page
  44. Potter, 2005, Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state, J. Biol. Chem., 280, 31906, 10.1074/jbc.M505568200 · DOI · Paper page
  45. Prewitt, 2015, Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension, J. Biol. Chem., 290, 960, 10.1074/jbc.M114.591057 · DOI
  46. Rosendahl, 2002, Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation, Am. J. Respir. Cell Mol. Biol., 27, 160, 10.1165/ajrcmb.27.2.4779 · DOI
  47. Rudini, 2008, VE-cadherin is a critical endothelial regulator of TGF-beta signalling, EMBO J., 27, 993, 10.1038/emboj.2008.46 · DOI
  48. Sanvitale, 2013, A new class of small molecule inhibitor of BMP signaling, PLoS ONE, 8, e62721, 10.1371/journal.pone.0062721 · DOI · Paper page
  49. Scharpfenecker, 2007, BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis, J. Cell Sci., 120, 964, 10.1242/jcs.002949 · DOI · Paper page
  50. Sidibe, 2014, VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs, Am. J. Physiol. Heart Circ. Physiol., 307, H455, 10.1152/ajpheart.00774.2013 · DOI
  51. Sieber, 2009, Recent advances in BMP receptor signaling, Cytokine Growth Factor Rev., 20, 343, 10.1016/j.cytogfr.2009.10.007 · DOI · Paper page
  52. Simic, 2006, Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption, J. Biol. Chem., 281, 25509, 10.1074/jbc.M513276200 · DOI · Paper page
  53. Sorescu, 2003, Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response, J. Biol. Chem., 278, 31128, 10.1074/jbc.M300703200 · DOI · Paper page
  54. Sorescu, 2004, Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase, Circ. Res., 95, 773, 10.1161/01.RES.0000145728.22878.45 · DOI · Paper page
  55. Thawani, 2010, Bone morphogenetic proteins and cancer: review of the literature, Neurosurgery, 66, 233, 10.1227/01.NEU.0000363722.42097.C2 · DOI
  56. Thymiakou, 2011, Detection of signaling effector-complexes downstream of BMP4 using in situ PLA, a proximity ligation assay, J. Vis. Exp., e2631, 10.3791/2631 · DOI
  57. Valdimarsdottir, 2002, Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells, Circulation, 106, 2263, 10.1161/01.CIR.0000033830.36431.46 · DOI · Paper page
  58. Vukicevic, 2014, The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing, Int. Orthop., 38, 635, 10.1007/s00264-013-2201-1 · DOI
  59. Wallez, 2007, Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site, Oncogene, 26, 1067, 10.1038/sj.onc.1209855 · DOI · Paper page
  60. Walshe, 2009, TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature, PLoS ONE, 4, e5149, 10.1371/journal.pone.0005149 · DOI · Paper page
  61. Weis, 2005, Pathophysiological consequences of VEGF-induced vascular permeability, Nature, 437, 497, 10.1038/nature03987 · DOI · Paper page
  62. Wong, 2005, Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension, Am. J. Respir. Cell Mol. Biol., 33, 438, 10.1165/rcmb.2005-0103OC · DOI · Paper page
  63. Xiao, 2003, Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells, J. Biol. Chem., 278, 19199, 10.1074/jbc.M211746200 · DOI · Paper page
  64. Xiao, 2003, Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells, J. Cell Biol., 163, 535, 10.1083/jcb.200306001 · DOI · Paper page
  65. Xiao, 2005, p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin, Mol. Biol. Cell, 16, 5141, 10.1091/mbc.E05-05-0440 · DOI · Paper page

Cited by

See all 81

Metadata

Authors
Benn, A., Bredow, C., Casanova, I., Vukičević, S., & Knaus, P.
Venue
Journal of Cell Science
Published
2016-01-01
Volume
129
Issue
1
Pages
206-218
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2177201093
Cited by
81
References
6
FWCI
2.70
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.